logo
NasdaqGS:LIVN logo

LivaNova Community

NasdaqGS:LIVN Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

LIVN logo
LivaNova
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts

Investment In Obstructive Sleep Apnea And DTD Therapies Will Strengthen Future Market Position

Key Takeaways Strategic focus on obstructive sleep apnea and cardiopulmonary advancements is key for revenue growth and market expansion. Operational efficiency through talent transformation and R&D investment aims to diversify revenue streams and improve margins.
View narrative
US$59.90
FV
30.1% undervalued intrinsic discount
4.87%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
7 days ago author updated this narrative